|
Market Closed -
Sapporo S.E.
20:00:04 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 960.00 JPY | +1.59% |
|
+5.15% | +5.38% |
| Market Cap | 19.73B 125M 111M 104M 94.84M 179M 12.06B 181M 1.26B 487M 6.14B 470M 460M | P/E 2025 |
7.62x | P/E 2026 | 11.4x |
|---|---|---|---|---|---|
| Enterprise Value | 2.65B 16.86M 14.97M 14M 12.76M 24.02M 1.62B 24.35M 169M 65.57M 827M 63.29M 61.92M | EV / Sales 2025 |
-
| EV / Sales 2026 | 0.01x |
| Free-Float |
42.96% | Yield 2025 |
2.25% | Yield 2026 | 2.17% |
| 1 day | +1.59% | ||
| 1 week | +5.15% | ||
| Current month | +1.59% | ||
| 1 month | +4.35% | ||
| 3 months | +6.08% | ||
| 6 months | +4.23% | ||
| Current year | +5.38% |
| 1 week | 910 | 960 | |
| 1 month | 906 | 960 | |
| Current year | 856 | 1,000 | |
| 1 year | 856 | 1,000 | |
| 3 years | 699 | 1,052 | |
| 5 years | 581 | 1,052 | |
| 10 years | 581 | 1,052 |
| Manager | Title | Age | Since |
|---|---|---|---|
Masanobu Manabe
PSD | President | 59 | 2018-05-31 |
| Chief Administrative Officer | 63 | 2022-02-28 | |
Atsushi Miyazaki
PRN | Corporate Officer/Principal | 66 | 2019-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Masaaki Manabe
CHM | Chairman | 83 | 2018-05-31 |
| Director/Board Member | 70 | 2010-06-09 | |
Tomohiro Manabe
BRD | Director/Board Member | 57 | 2009-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.59% | +5.15% | +5.84% | +31.51% | 124M | ||
| -0.62% | -2.71% | +39.30% | +113.61% | 1,031B | ||
| -2.30% | -4.44% | +39.03% | +66.72% | 638B | ||
| -0.63% | -1.96% | +6.36% | +75.33% | 462B | ||
| -1.03% | -2.82% | +59.56% | +40.23% | 359B | ||
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | ||
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | ||
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | ||
| -3.38% | +0.30% | +36.44% | +52.93% | 228B | ||
| -1.04% | -1.46% | +32.70% | +99.06% | 185B | ||
| Average | -0.93% | +0.02% | +27.90% | +55.29% | 376.4B | |
| Weighted average by Cap. | -1.02% | -0.35% | +32.51% | +69.53% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 290B 1.84B 1.63B 1.53B 1.39B 2.62B 177B 2.66B 18.47B 7.15B 90.14B 6.9B 6.75B | 304B 1.93B 1.71B 1.6B 1.46B 2.75B 186B 2.79B 19.37B 7.5B 94.54B 7.24B 7.08B |
| Net income | 2.47B 15.7M 13.94M 13.04M 11.88M 22.37M 1.51B 22.67M 158M 61.06M 770M 58.93M 57.65M | 1.68B 10.69M 9.49M 8.88M 8.09M 15.23M 1.03B 15.44M 107M 41.57M 524M 40.12M 39.25M |
| Net Debt | -17.73B -113M -99.97M -93.49M -85.2M -160M -10.84B -163M -1.13B -438M -5.52B -423M -413M | -17.08B -108M -96.32M -90.07M -82.08M -155M -10.44B -157M -1.09B -422M -5.32B -407M -398M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | JP¥960.00 | +1.59% | 300 |
| 26-09-30 | JP¥945.00 | +0.53% | 400 |
| 26-09-29 | JP¥940.00 | +1.29% | 900 |
| 26-09-28 | JP¥928.00 | +1.20% | 900 |
| 26-09-25 | JP¥917.00 | -0.11% | 1,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 3055 Stock
Select your edition
All financial news and data tailored to specific country editions
















